Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Stocks Sink As Rates And The U.S. Dollar Surge

Published 06/02/2022, 01:09 AM
Updated 09/20/2023, 06:34 AM

The S&P 500 finished lower by 75 bps Wednesday, to close at 4,101. The index plunged following the ISM report showing the Fed has made nearly no progress in its attempt to slow economic growth or reign in inflation.

That sent the dollar and yields soaring. The weak dollar and falling rates helped push stocks higher last week. This week, the stronger dollar and rising rates are helping to sink stocks.

As long as the paths of the dollar and rates remain higher, the course for stocks may remain lower.

Again, one of the easiest ways to visualize this relationship is to look at the iShares TIPS Bond ETF (NYSE:TIP) vs. the Invesco QQQ Trust ETF (NASDAQ:QQQ).

The two have tracked each other nearly perfectly since the winter of 2018. When the TIP made new highs, the QQQ made a new high for years.

Now, as the TIP has reversed, so has the QQQ. Interestingly, the TIP made a new closing low yesterday. If the pattern continues, it would indicate that a new low for the QQQ may only be around the corner.

It doesn’t mean the QQQ has to make a new low, but given the strength of the relationship over the years, the odds seem high it does.

TIPS Bond ETF Daily Chart

JPMorgan

As hot as the banks were last week, this week they are not. JPMorgan Chase & Co (NYSE:JPM) fell by almost 2% today after its CEO, Jamie Dimon warned of an economic hurricane coming.

After the stock hit its 61.8% retracement level Tuesday, the rally could be over after forming a bearish engulfing candle yesterday. If that were the end of the rally, I would not be surprised to see the stock trading sub-$115 again.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

JPMorgan Daily Chart

S&P Global

Today, S&P Global (NYSE:SPGI) fell by 5% after it pulled its 2022 financial guidance on weak debt issuances. The stock initially fell to technical support at $310 and bounced hard to close at $332.

The momentum on the RSI looks very bearish, in my opinion, leaving me to think that $310 may be tested again soon.

S&P Global Daily Chart

Bristol-Myers

Finally, I haven’t looked at Bristol-Myers Squibb (NYSE:BMY) in a long time, and you can see the stock has been trading sideways for some time and is now making a bearish divergence with that relative strength index turning sharply lower.

There is also a gap that needs to be filled, around $70.

Bristol-Myers Daily Chart

Original Post

Latest comments

Pẹlẹ o bawo ni
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.